U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995-.

Cover of Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].

Show details

Effectiveness of methylprednisolone in acute spinal cord injury: a systematic review of randomized controlled trials

Review published: .

Bibliographic details: Botelho RV, Daniel JW, Boulosa JL, Colli BO, de Lucena Farias R, Moraes OJ, Pimenta WE, Ribeiro CH, Borges Ribeiro FR, Taricco MA, de Carvalho MV, Bernardo WM.  Effectiveness of methylprednisolone in acute spinal cord injury: a systematic review of randomized controlled trials. Revista da Associacao Medica Brasileira 2009; 55(6): 729-737. [PubMed: 20191229]

Abstract

Steroid therapy has been tested as a protector in spinal cord injury. Multicenter studies evaluating the methylprednisolone (MP) in post traumatic neurological recovery have shown promising results according to NASCIS. A large number of critical studies related to the NASCIS results have been published.

OBJECTIVE: To review literature related to use of methylprednisolone compared with placebo.

METHODS: This analysis added the average improvement achieved in groups of patients who used MP and placebo (PL) to the average scores of groups at baseline, before treatment, resulting in the final neurological outcome for both groups.

RESULTS: The motor score of the MP group was only 2.5 points higher than the PL in a one year follow-up. In neurologically intact patients, the total score is 70 points. Improvement in sensitive scores was also discrete (1.1 and 1.7 points for the pinprick and light touch respectively). A high rate of complications was observed in a group of patients about 60 years old who used MP.

CONCLUSION: Differences in the clinical magnitude of benefit obtained (not confirmed by other studies) with the use of MP or PL are not significant, in comparison with the potential for complications when using methylprednisolone.

Copyright © 2014 University of York.
Bookshelf ID: NBK76921

Views

  • PubReader
  • Print View
  • Cite this Page

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...